Douglas Flora: How enhanced cancer screening with AI tools help drive smarter cancer care
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:
“Real progress in cancer screening will take a new set of eyes.
The standardized cancer screening paradigms—mammograms for women over 40, colonoscopies after 45, low-dose CT for longtime smokers—represented the best we could achieve with limited tools for risk stratification. But this approach has always contained an inherent inefficiency. We screen many who will never develop the disease while simultaneously missing others at high risk who fall outside conventional screening parameters.
Today’s Substack piece challenges those old paradigms, examining how AI is revolutionizing the way we screen for cancer. Let’s work smarter, not harder. To quote Eric Topol, MD, its time we ‘upend’ cancer screening.
Modern paradigms must involve a shift from exclusive reliance on human perception to a cognitive partnership between human and artificial intelligence. AI systems detect patterns imperceptible to human observers, maintain consistent performance across thousands of cases, and integrate information across modalities.
Read on to see how enhanced cancer screening with AI tools help drive smarter cancer care.
(Excerpt from Chapter 5 of CTRL+ALT+CURE: Rebooting Cancer Care, coming soon.)”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023